Akumin Inc. (AKU) Research

Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States. Its operations are divided into two main divisions: Radiology and Oncology. Through a network of roughly 200 imaging centers, which it either owns or manages, Akumin delivers a wide array of medical imaging modalities. These include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and various other diagnostic or interventional radiology procedures. The company extends its outpatient radiology and oncology services and comprehensive solutions to approximately 1,000 hospitals and healthcare systems spanning 46 states. Established in 2015, Akumin Inc. maintains its corporate headquarters in Plantation, Florida.

Market snapshot

Symbol
AKU
Price
$0.29
Day change
-17.87%
Market cap
$26.3M
P/E ratio
-0.17x
52-week range
0.118-1.9
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Analyst price target
$3.00

Peer companies

  • Abingdon Health Plc (ABDXF)
  • Aspira Women's Health Inc. (AWH)
  • Centogene N.V. (CNTG)
  • DermTech, Inc. (DMTKQ)
  • LumiraDx Limited (LMDX)
  • 23andMe Holding Co. (ME)
  • MDxHealth S.A. (MXDHF)
  • Invitae Corporation (NVTA)

Recent insider activity

  • Bienias Ronald J. — trade (0 shares) on 2023-10-20
  • Kumar Krishna — A-Award (250000 shares) on 2023-07-15
  • Stonepeak GP Investors Holdings LP — trade (0 shares) on 2023-06-26
  • Stonepeak GP Investors Holdings LP — trade (17114093 shares) on 2023-06-26
  • Kumar Krishna — trade (0 shares) on 2023-06-16

Open Akumin Inc. (AKU) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.